Angry Gut: Irritable Bowel Syndrome


  • Izrum Shafi Rajput
  • Syed Ijaz Hussain Zaidi
  • Muhammad Sajid Abbas Jaffri
  • Syed Wajahat Hasib
  • Kashif Razaq



Constipation, Diarrhea, Irritable bowel syndrome, ROME IV criteria.


Irritable bowel syndrome (IBS) is a functional disorder of the intestine characterized by abdominal pain and altered bowel
habits. At present, no biological marker has been identified. Hence, the disease is clinically assessed on the basis of the
symptoms according to ROME IV criteria. Epidemiological data revealed that the prevalence of IBS varies widely around
the world, and more thorough research is needed to pinpoint any discrepancies that may exist between countries, as well
as possible reasons. Both pharmacological and non-pharmacological therapy is being used in order to treat IBS. There is
no specific treatment for irritable bowel disease that has come across the patients and only possible measures have been
taken to treat the severity of symptoms. Symptomatic treatment with spasmolytic agent like mebeverine has been considered
a standard therapy to relieve pain but to deal with constipation and diarrhea different treatment modalities have been adopted
by the physician


Ng QX, Soh AY, Loke W, Lim DY, Yeo WS. The role of

inflammation in irritable bowel syndrome (IBS). Journal of

inflammation research. 2018;11:345. doi: 10.2147/JIR.S174982

Ford AC. Commentary: estimating the prevalence of IBS

globally—past, present and future. Alimentary pharmacology

& therapeutics. 2020;51(1):198-9.


Vork L, Weerts ZZ, Mujagic Z, Kruimel JW, Hesselink MA,

Muris JW, Keszthelyi D, Jonkers DM, Masclee AA. Rome

III vs Rome IV criteria for irritable bowel syndrome: A

comparison of clinical characteristics in a large cohort study.

Neurogastroenterology & Motility. 2018;30(2):e13189.https://

Holtmann GJ, Ford AC, Talley NJ. Pathophysiology of irritable

bowel syndrome. The lancet Gastroenterology & hepatology.



El-Salhy M, Hausken T, Gilja OH, Hatlebakk JG. The possible

role of gastrointestinal endocrine cells in the pathophysiology

of irritable bowel syndrome. Expert review of gastroenterology

& hepatology. 2017;11(2):139-48.


Masuy I, Van Oudenhove L, Tack J, Biesiekierski JR. Effect

of intragastric FODMAP infusion on upper gastrointestinal

motility, gastrointestinal, and psychological symptoms in

irritable bowel syndrome vs healthy controls. Neurogastroenterology & Motility. 2018;30(1):e13167.


Barros LL, Farias AQ, Rezaie A. Gastrointestinal motility

and absorptive disorders in patients with inflammatory bowel

diseases: Prevalence, diagnosis and treatment. World journal

of gastroenterology. 2019;25(31):4414. doi: 10.3748/wjg.v25.

i31. 4414

Fuentes IM, Christianson JA. Ion channels, ion channel

receptors, and visceral hypersensitivity in irritable bowel

syndrome. Neurogastroenterology & Motility.


Farzaei MH, Bahramsoltani R, Abdollahi M, Rahimi R. The

role of visceral hypersensitivity in irritable bowel syndrome:

pharmacological targets and novel treatments. Journal of

Neurogastroenterology and Motility. 2016;22(4):558. doi:

5056/ jnm16001

Sasaki A, Sato N, Suzuki N, Kano M, Tanaka Y, Kanazawa

M, Aoki M, Fukudo S. Associations between single-nucleotide

polymorphisms in corticotropin-releasing hormone-related

genes and irritable bowel syndrome. PloS one. 2016 Feb

;11(2):e0149322. 10.1371/journal.pone.

Zhu S, He M, Liu Z, Qin Z, Wang Z, Duan L. Shared genetic

susceptibilities for irritable bowel syndrome and depressive

disorder in Chinese patients uncovered by pooled wholeexome sequencing. Journal of advanced research. 2020;23:113- jare.2020.01.016

Henström M, D’Amato M. Genetics of irritable bowel

syndrome. Molecular and cellular pediatrics. 2016;3(1):1-5.

Bhattarai Y, Muniz Pedrogo DA, Kashyap PC. Irritable bowel

syndrome: a gut microbiota-related disorder?. American

Journal of Physiology-Gastrointestinal and Liver Physiology.

; 312(1):G52-62.

Harris LA, Baffy N. Modulation of the gut microbiota: a focus

on treatments for irritable bowel syndrome. Postgraduate

medicine. 2017;129(8):872-88. 080/0


Wang Z, Xu CM, Liu YX, Wang XQ, Zhang L, Li M, Zhu

SW, Xie ZJ, Wang PH, Duan LP, Zhu HQ. Characteristic

dysbiosis of gut microbiota of Chinese patients with diarrheapredominant irritable bowel syndrome by an insight into the

pan-microbiome. Chinese medical journal. 2019;132(8):889.

Volta U, Pinto-Sanchez MI, Boschetti E, Caio G, De Giorgio

R, Verdu EF. Dietary triggers in irritable bowel syndrome: is

there a role for gluten?. Journal of Neurogastroenterology

and Motility. 2016;22(4):547.doi: 10.5056/jnm16069

Moser G, Fournier C, Peter J. Intestinal microbiome-gut-brain

axis and irritable bowel syndrome. Wiener Medizinische

Wochenschrift. 2018;168(3):62-6.


Pellissier S, Bonaz B. The place of stress and emotions in the

irritable bowel syndrome. Vitamins and hormones. 2017;


Peleman C, Camilleri M, Busciglio I, Burton D, Donato L,

Zinsmeister AR. Colonic transit and bile acid synthesis or

excretion in patients with irritable bowel syndrome–diarrhea

without bile acid malabsorption. Clinical Gastroenterology

and Hepatology. 2017;15(5):720-7.


0. Jeffery IB, Das A, O’Herlihy E, Coughlan S, Cisek K, Moore

M, Bradley F, Carty T, Pradhan M, Dwibedi C, Shanahan F.

Differences in fecal microbiomes and metabolomes of people

with vs without irritable bowel syndrome and bile acid

malabsorption. Gastroenterology. 2020;158(4):1016-28.

Barbara G, Cremon C, Azpiroz F. Probiotics in irritable bowel

syndrome: Where are we?. Neurogastroenterology & Motility.


Principi N, Cozzali R, Farinelli E, Brusaferro A, Esposito S.

Gut dysbiosis and irritable bowel syndrome: The potential

role of probiotics. Journal of Infection. 2018;76(2):111-20.

Oh JH, Jang YS, Kang D, Chang DK, Min YW. Efficacy and

safety of new Lactobacilli probiotics for unconstipated irritable

bowel syndrome: A randomized, double-blind, placebocontrolled trial. Nutrients. 2019;11(12):2887.


Shastri MD, Chong WC, Vemuri R, Martoni CJ, Adhikari S,

Bhullar H, Kunde D, Tristram SG, Eri RD. Streptococcus

thermophilus UASt-09 upregulates goblet cell activity in

colonic epithelial cells to a greater degree than other probiotic

strains. Microorganisms. 2020;8(11):1758.

3390 /microorganisms8111758

Gayathri R, Aruna T, Malar S, Shilpa B, Dhanasekar KR.

Efficacy of Saccharomyces cerevisiae CNCM I-3856 as an

add-on therapy for irritable bowel syndrome. International

journal of colorectal disease. 2020;35(1):139-45.


Harper A, Naghibi MM, Garcha D. The role of bacteria,

probiotics and diet in irritable bowel syndrome. Foods. 2018


Barbalho SM, Goulart RD, Araújo AC, Guiguer ÉL, Bechara

MD. Irritable bowel syndrome: a review of the general aspects

and the potential role of vitamin D. Expert review of

gastroenterology & hepatology. 2019;13(4):345-59. 10.1080/17474124.2019.1570137

Nwosu BU, Maranda L, Candela N. Vitamin D status in

pediatric irritable bowel syndrome. PLoS One.

;12(2):e0172183. journal.


Jalili M, Vahedi H, Poustchi H, Hekmatdoost A. Effects of

vitamin D supplementation in patients with irritable bowel

syndrome: a randomized, double-blind, placebo-controlled

clinical trial. International journal of preventive medicine.

;10. doi: 10.4103/ijpvm.IJPVM_512_17

Hong SW, Chun J, Park S, Lee HJ, Im JP, Kim JS. Aloe vera

is effective and safe in short-term treatment of irritable bowel

syndrome: a systematic review and meta-analysis. Journal of

neurogastroenterology and motility. 2018;24(4):528. doi:


Dimidi E, Whelan K. Food supplements and diet as treatment

options in irritable bowel syndrome. Neurogastroenterology

& Motility. 2020; 32(8):e13951. 1111/


Weerts ZZ, Masclee AA, Witteman BJ, Clemens CH, Winkens

B, Brouwers JR, Frijlink HW, Muris JW, De Wit NJ, Essers

BA, Tack J. Efficacy and safety of peppermint oil in a

randomized, double-blind trial of patients with irritable bowel

syndrome. Gastroenterology. 2020;158(1):123-36. https://doi.


Weerts ZZ, Keszthelyi D, Vork L, Aendekerk NC, Frijlink

HW, Brouwers JR, Neef C, Jonkers DM, Masclee AA. A

novel ileocolonic release peppermint oil capsule for treatment

of irritable bowel syndrome: A phase I study in healthy

volunteers. Advances in therapy. 2018;35(11):1965-

Cash BD, Epstein MS, Shah SM. A novel delivery system of

peppermint oil is an effective therapy for irritable bowel

syndrome symptoms. Digestive diseases and sciences.


Kinsinger SW. Cognitive-behavioral therapy for patients with

irritable bowel syndrome: current insights. Psychology research

and behavior management. 2017;10:231.doi: 10.2147/ PRBM.


El-Salhy M, Ystad SO, Mazzawi T, Gundersen D. Dietary

fiber in irritable bowel syndrome. International journal of

molecular medicine. 2017;40(3):607-13.


Zhuang Z, Chen M, Niu J, Qu N, Ji B, Duan X, Liu Z, Liu

X, Wang Y, Zhao B. The manufacturing process of kiwifruit

fruit powder with high dietary fiber and its laxative effect.

Molecules. 2019;24(21):3813. https://doi. org/10.3390

/molecules 24213813

Taylor AM, Holscher HD. A review of dietary and microbial

connections to depression, anxiety, and stress. Nutritional

neuroscience. 2020;23(3):237-50.


Oskouie FH, Vahedi H, Shahrbaf MA, Sadeghi A, Rashidkhani

B, Hekmatdoost A. Dietary fiber and risk of irritable bowel

syndrome: a case-control study. Gastroenterology and

hepatology from bed to bench. 2018;11(Suppl 1):S20. doi:


Casado-Bedmar M, Keita ÅV. Potential neuro-immune

therapeutic targets in irritable bowel syndrome. Therapeutic

advances in gastroenterology. 2020;13:1756284820910630.

Garg P. Inflammation in Irritable Bowel Syndrome (IBS):

Role of Psyllium Fiber Supplementation in Decreasing

Inflammation and Physiological Management of IBS. Turk

J Gastroenterol. 2021;32(1):108-10. DOI: 10.5152/ tjg.2020.

Radovanovic-Dinic B, Tesic-Rajkovic S, Grgov S, Petrovic

G, Zivkovic V. Irritable bowel syndrome-from etiopathogenesis

to therapy. Biomedical Papers of the Medical Faculty of

Palacky University in Olomouc. 2018;162(1). https://doi. org/


Chen L, Ilham SJ, Feng B. Pharmacological approach for

managing pain in irritable bowel syndrome: a review article.

Anesthesiology and pain medicine. 2017;7(2).doi:


Yang Y, Fang J, Guo X, Dai N, Shen X, Yang Y, Sun J,

Bhandari BR, Reasner DS, Cronin JA, Currie MG. Linaclotide

in irritable bowel syndrome with constipation: a phase 3

randomized trial in China and other regions. Journal of

gastroenterology and hepatology. 2018;33(5):980-9.

Song KH, Jung HK, Kim HJ, Koo HS, Kwon YH, Shin HD,

Lim HC, Shin JE, Kim SE, Cho DH, Kim JH. Clinical practice

guidelines for irritable bowel syndrome in Korea. Journal of

neurogastroenterology and motility. 2018;24(2):197. doi:


Barney VA, Hernández AF. The role of antispasmodics in

managing irritable bowel syndrome. Rev Colomb

Gastroenterol. 2019;34(3):267-73.


Evangelista S, Traini C, Vannucchi MG. Otilonium Bromide:

a drug with a complex mechanism of action. Current pharmaceutical design. 2018;24(16):1772-9. 10.2174/

Schmulson MJ, Chiu-Ugalde J, Sáez-Ríos A, López-Colombo

A, Mateos-Pérez GJ, Remes-Troche JM, Sobrino-Cossio S,

Soto-Pérez JC, de la Cuesta JL, Teramoto-Matsubara OT,

López-Alvarenga JC. Efficacy of the combination of

pinaverium bromide 100 mg plus simethicone 300 mg in

abdominal pain and bloating in irritable bowel syndrome: a

randomized, placebo-controlled trial. Journal of Clinical

Gastroenterology. 2020;54(4):e30.


Heghes SC, Vostinaru O, Rus LM, Mogosan C, Iuga CA,

Filip L. Antispasmodic effect of essential oils and their

constituents: A review. Molecules. 2019;24(9):1675.

Hatami K, Kazemi Motlagh A, Ajdarkosh H, Zargaran A,

Karimi M, SHAMSHIRI A, GHADIR M. Comparing the

Efficacy of Cumin Sofouf With Mebeverine on Irritable Bowel

Syndrome Severity and Quality of Life: A Double-blind

Randomized Clinical Trial. Crescent Journal of Medical and

Biological Sciences. 2020;7(2):186-94. eISSN 2148-9696

Chakraborty DS, Hazra A, Sil A, Pain S. Will controlled

release mebeverine be able to surpass placebo in treatment

of diarrhoea predominant irritable bowel syndrome?. Journal

of family medicine and primary care. 2019;8(10):3173. doi:





How to Cite

Rajput, I. S. ., Zaidi, S. I. H. ., Jaffri, M. S. A. ., Hasib, S. W. ., & Razaq, K. . (2022). Angry Gut: Irritable Bowel Syndrome. Journal of Bahria University Medical and Dental College, 12(02), 105–111.



Review Article

Most read articles by the same author(s)